1. Home
  2. PBHC vs SCLX Comparison

PBHC vs SCLX Comparison

Compare PBHC & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

HOLD

Current Price

$14.34

Market Cap

87.8M

Sector

Finance

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$11.02

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBHC
SCLX
Founded
1859
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.8M
90.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PBHC
SCLX
Price
$14.34
$11.02
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
3.1K
75.9K
Earning Date
01-30-2026
11-14-2025
Dividend Yield
2.81%
N/A
EPS Growth
N/A
N/A
EPS
1.07
N/A
Revenue
$44,154,000.00
$40,360,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$749.70
P/E Ratio
$13.35
N/A
Revenue Growth
24.40
N/A
52 Week Low
$13.35
$3.60
52 Week High
$17.50
$34.27

Technical Indicators

Market Signals
Indicator
PBHC
SCLX
Relative Strength Index (RSI) 51.18 29.55
Support Level $13.96 $11.10
Resistance Level $14.38 $13.83
Average True Range (ATR) 0.30 0.97
MACD 0.06 -0.05
Stochastic Oscillator 86.08 3.83

Price Performance

Historical Comparison
PBHC
SCLX

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: